Asset Management - Global
Compare Stocks
5 / 10Stock Comparison
GROW vs CSWC vs ARCC vs DHIL vs GBDC
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management
GROW vs CSWC vs ARCC vs DHIL vs GBDC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management - Global | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $35M | $1.43B | $13.61B | $473M | $3.43B |
| Revenue (TTM) | $8M | $164M | $3.15B | $158M | $871M |
| Net Income (TTM) | $98K | $103M | $1.15B | $49M | $205M |
| Gross Margin | 41.7% | 66.5% | 75.7% | 96.0% | 81.5% |
| Operating Margin | -35.3% | 48.5% | 69.7% | 38.4% | 78.9% |
| Forward P/E | — | 10.1x | 9.9x | 9.5x | 9.2x |
| Total Debt | $83K | $956M | $15.99B | $6.40B | $4.90B |
| Cash & Equiv. | $25M | $43M | $924M | $42M | $24M |
GROW vs CSWC vs ARCC vs DHIL vs GBDC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| U.S. Global Investo… (GROW) | 100 | 125.4 | +25.4% |
| Capital Southwest C… (CSWC) | 100 | 171.6 | +71.6% |
| Ares Capital Corpor… (ARCC) | 100 | 128.5 | +28.5% |
| Diamond Hill Invest… (DHIL) | 100 | 164.0 | +64.0% |
| Golub Capital BDC, … (GBDC) | 100 | 108.3 | +8.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GROW vs CSWC vs ARCC vs DHIL vs GBDC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GROW lags the leaders in this set but could rank higher in a more targeted comparison.
CSWC is the #2 pick in this set and the best alternative if long-term compounding and bank quality is your priority.
- 234.2% 10Y total return vs ARCC's 139.2%
- NIM 7.0% vs DHIL's 0.7%
- +34.0% vs ARCC's +0.4%
Among these 5 stocks, ARCC doesn't own a clear edge in any measured category.
DHIL ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.57, yield 5.7%
- Lower volatility, beta 0.57, current ratio 75115.85x
- Beta 0.57, yield 5.7%, current ratio 75115.85x
- Beta 0.57 vs CSWC's 0.84
GBDC carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 42.5%, EPS growth 4.4%
- PEG 0.30 vs DHIL's 1.14
- 42.5% NII/revenue growth vs GROW's -23.1%
- Lower P/E (9.2x vs 9.5x), PEG 0.30 vs 1.14
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 42.5% NII/revenue growth vs GROW's -23.1% | |
| Value | Lower P/E (9.2x vs 9.5x), PEG 0.30 vs 1.14 | |
| Quality / Margins | Efficiency ratio 0.0% vs GROW's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.57 vs CSWC's 0.84 | |
| Dividends | 10.5% yield, vs CSWC's 10.2% | |
| Momentum (1Y) | +34.0% vs ARCC's +0.4% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs GROW's 0.8% |
GROW vs CSWC vs ARCC vs DHIL vs GBDC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
GROW vs CSWC vs ARCC vs DHIL vs GBDC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GBDC leads in 2 of 6 categories
CSWC leads 1 • DHIL leads 1 • GROW leads 0 • ARCC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GBDC leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 372.1x GROW's $8M. GBDC is the more profitable business, keeping 43.2% of every revenue dollar as net income compared to GROW's -4.0%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $8M | $164M | $3.1B | $158M | $871M |
| EBITDAEarnings before interest/tax | -$2M | $142M | $2.0B | $62M | $431M |
| Net IncomeAfter-tax profit | $98,000 | $103M | $1.1B | $49M | $205M |
| Free Cash FlowCash after capex | -$235,000 | -$69M | $1.1B | $44.5B | $313M |
| Gross MarginGross profit ÷ Revenue | +41.7% | +66.5% | +75.7% | +96.0% | +81.5% |
| Operating MarginEBIT ÷ Revenue | -35.3% | +48.5% | +69.7% | +38.4% | +78.9% |
| Net MarginNet income ÷ Revenue | -4.0% | +43.1% | +41.3% | +30.9% | +43.2% |
| FCF MarginFCF ÷ Revenue | -9.8% | -132.6% | +36.3% | -57.4% | -13.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +113.3% | -63.9% | +25.3% | -160.0% |
Valuation Metrics
GBDC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, GBDC trades at a 43% valuation discount to CSWC's 16.3x P/E. Adjusting for growth (PEG ratio), GBDC offers better value at 0.30x vs DHIL's 1.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $35M | $1.4B | $13.6B | $473M | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $10M | $2.3B | $28.7B | $6.8B | $8.3B |
| Trailing P/EPrice ÷ TTM EPS | -104.80x | 16.32x | 10.19x | 9.77x | 9.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.06x | 9.92x | 9.48x | 9.15x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.99x | 1.18x | 0.30x |
| EV / EBITDAEnterprise value multiple | — | 27.43x | 13.09x | 110.39x | 12.08x |
| Price / SalesMarket cap ÷ Revenue | 4.14x | 8.71x | 4.33x | 3.00x | 3.93x |
| Price / BookPrice ÷ Book value/share | 0.77x | 1.39x | 0.93x | 2.70x | 0.88x |
| Price / FCFMarket cap ÷ FCF | — | — | 11.92x | — | — |
Profitability & Efficiency
Evenly matched — GROW and DHIL each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
DHIL delivers a 27.0% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $0 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHIL's 36.26x. On the Piotroski fundamental quality scale (0–9), DHIL scores 6/9 vs CSWC's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.2% | +10.3% | +8.1% | +27.0% | +5.2% |
| ROA (TTM)Return on assets | +0.2% | +4.8% | +3.8% | +19.5% | +2.3% |
| ROICReturn on invested capital | -4.7% | +3.5% | +5.7% | +1.3% | +5.9% |
| ROCEReturn on capital employed | -6.2% | +4.6% | +7.5% | +26.0% | +7.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 1 | 4 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.00x | 1.08x | 1.12x | 36.26x | 1.23x |
| Net DebtTotal debt minus cash | -$24M | $913M | $15.1B | $6.4B | $4.9B |
| Cash & Equiv.Liquid assets | $25M | $43M | $924M | $42M | $24M |
| Total DebtShort + long-term debt | $83,000 | $956M | $16.0B | $6.4B | $4.9B |
| Interest CoverageEBIT ÷ Interest expense | 600.00x | 2.91x | 2.98x | — | 1.62x |
Total Returns (Dividends Reinvested)
CSWC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSWC five years ago would be worth $15,138 today (with dividends reinvested), compared to $4,143 for GROW. Over the past 12 months, CSWC leads with a +34.0% total return vs ARCC's +0.4%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs GROW's 1.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.7% | +11.4% | -4.9% | +2.8% | -0.7% |
| 1-Year ReturnPast 12 months | +27.8% | +34.0% | +0.4% | +33.8% | +3.3% |
| 3-Year ReturnCumulative with dividends | +3.3% | +75.8% | +34.2% | +22.4% | +35.3% |
| 5-Year ReturnCumulative with dividends | -58.6% | +51.4% | +47.0% | +28.3% | +33.2% |
| 10-Year ReturnCumulative with dividends | +67.4% | +234.2% | +139.2% | +55.4% | +61.0% |
| CAGR (3Y)Annualised 3-year return | +1.1% | +20.7% | +10.3% | +7.0% | +10.6% |
Risk & Volatility
DHIL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DHIL is the less volatile stock with a 0.57 beta — it tends to amplify market swings less than CSWC's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHIL currently trades 100.0% from its 52-week high vs GROW's 71.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 0.84x | 0.77x | 0.57x | 0.64x |
| 52-Week HighHighest price in past year | $3.65 | $24.43 | $23.42 | $175.03 | $15.63 |
| 52-Week LowLowest price in past year | $2.10 | $19.37 | $17.40 | $114.11 | $11.77 |
| % of 52W HighCurrent price vs 52-week peak | +71.8% | +98.2% | +81.0% | +100.0% | +84.1% |
| RSI (14)Momentum oscillator 0–100 | 46.5 | 63.7 | 56.7 | 70.5 | 52.8 |
| Avg Volume (50D)Average daily shares traded | 25K | 664K | 7.5M | 23K | 2.4M |
Analyst Outlook
Evenly matched — CSWC and GBDC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CSWC as "Buy", ARCC as "Buy", GBDC as "Buy". Consensus price targets imply 15.4% upside for ARCC (target: $22) vs -6.2% for CSWC (target: $23). For income investors, GBDC offers the higher dividend yield at 10.53% vs ARCC's 2.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | $22.50 | $21.88 | — | $14.33 |
| # AnalystsCovering analysts | — | 10 | 32 | — | 11 |
| Dividend YieldAnnual dividend ÷ price | +3.5% | +10.2% | +2.0% | +5.7% | +10.5% |
| Dividend StreakConsecutive years of raises | 1 | 3 | 0 | 1 | 0 |
| Dividend / ShareAnnual DPS | $0.09 | $2.45 | $0.38 | $9.98 | $1.38 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% | 0.0% | +3.6% | +2.3% |
GBDC leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). CSWC leads in 1 (Total Returns). 2 tied.
GROW vs CSWC vs ARCC vs DHIL vs GBDC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GROW or CSWC or ARCC or DHIL or GBDC a better buy right now?
For growth investors, Golub Capital BDC, Inc.
(GBDC) is the stronger pick with 42. 5% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Golub Capital BDC, Inc. (GBDC) offers the better valuation at 9. 3x trailing P/E (9. 2x forward), making it the more compelling value choice. Analysts rate Capital Southwest Corporation (CSWC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GROW or CSWC or ARCC or DHIL or GBDC?
On trailing P/E, Golub Capital BDC, Inc.
(GBDC) is the cheapest at 9. 3x versus Capital Southwest Corporation at 16. 3x. On forward P/E, Golub Capital BDC, Inc. is actually cheaper at 9. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Golub Capital BDC, Inc. wins at 0. 30x versus Diamond Hill Investment Group, Inc. 's 1. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GROW or CSWC or ARCC or DHIL or GBDC?
Over the past 5 years, Capital Southwest Corporation (CSWC) delivered a total return of +51.
4%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: CSWC returned +234. 2% versus DHIL's +55. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GROW or CSWC or ARCC or DHIL or GBDC?
By beta (market sensitivity over 5 years), Diamond Hill Investment Group, Inc.
(DHIL) is the lower-risk stock at 0. 57β versus Capital Southwest Corporation's 0. 84β — meaning CSWC is approximately 46% more volatile than DHIL relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Diamond Hill Investment Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GROW or CSWC or ARCC or DHIL or GBDC?
By revenue growth (latest reported year), Golub Capital BDC, Inc.
(GBDC) is pulling ahead at 42. 5% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Diamond Hill Investment Group, Inc. grew EPS 14. 4% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GROW or CSWC or ARCC or DHIL or GBDC?
Golub Capital BDC, Inc.
(GBDC) is the more profitable company, earning 43. 2% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 43. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GBDC leads at 78. 9% versus -35. 3% for GROW. At the gross margin level — before operating expenses — DHIL leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GROW or CSWC or ARCC or DHIL or GBDC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Golub Capital BDC, Inc. (GBDC) is the more undervalued stock at a PEG of 0. 30x versus Diamond Hill Investment Group, Inc. 's 1. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Golub Capital BDC, Inc. (GBDC) trades at 9. 2x forward P/E versus 10. 1x for Capital Southwest Corporation — 0. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARCC: 15. 4% to $21. 88.
08Which pays a better dividend — GROW or CSWC or ARCC or DHIL or GBDC?
All stocks in this comparison pay dividends.
Golub Capital BDC, Inc. (GBDC) offers the highest yield at 10. 5%, versus 2. 0% for Ares Capital Corporation (ARCC).
09Is GROW or CSWC or ARCC or DHIL or GBDC better for a retirement portfolio?
For long-horizon retirement investors, Diamond Hill Investment Group, Inc.
(DHIL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 57), 5. 7% yield). Both have compounded well over 10 years (DHIL: +55. 4%, ARCC: +139. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GROW and CSWC and ARCC and DHIL and GBDC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GROW is a small-cap income-oriented stock; CSWC is a small-cap deep-value stock; ARCC is a mid-cap high-growth stock; DHIL is a small-cap deep-value stock; GBDC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.